Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Can a model be developed to establish the risk of haemolysis in G6PD deficient individuals exposed to primaquine?
  • Can a safer regimen of primaquine be developed?
  • Can tafenoquine be used to eliminate P. vivax?
  • What is the optimum treatment of rickettsiosis infections?
  • Rural health: what are the main causes of fever in the rural population of Karen state? What are the village-based interventions that can reduce morbidity and mortality?